Release Date: 24/09/14 13:27 Summary: Reminder re $1.5m rights issue of shares and listed options Price Sensitive: No Download Document 224.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%